Autres langues Regeneron Pharmaceuticals, Inc.

Actions

REGN

US75886F1075

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 01/10/2026			Varia. 5j.	Varia. 1 janv.
734,81 ^USD	-3,09%		-7,69%	-4,80%

01/10	Regeneron Pharmaceuticals, Inc. : Jefferies & Co. n'est pas inspiré par le dossier	ZM
01/10	Regeneron affirme que le trevogrumab préserve la masse musculaire lors d’une perte de poids induite par les agonistes du GLP-1	MT

Autres langues

01/10	Healthcare Stocks Among Top Losers -- Healthcare Roundup
01/10	Aktien Europa Schluss: Ölpreise und Anleiherenditen belasten die Märkte
01/10	Regeneron Says Trevogrumab Preserves Muscle During GLP-1-Induced Weight Loss
01/10	Regeneron Says Ongoing Phase 1/2 Ovarian Cancer Trial With Ubamatamab Showed High Rate of Durable Responses
01/10	Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)
01/10	Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss
01/10	Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal -- Update
01/10	Analyst recommendations: Alphabet, Amazon, Micron, Tesla, Eli Lilly…
01/10	Tech setzt darauf, dass die Wirtschaft hohe Zinsen verkraftet
01/10	Exchange-Traded Funds, Equity Futures up Pre-Bell Thursday as Traders Assess Micron's Fiscal Q4 Results
01/10	Sanofi Expands Regeneron Partnership with Four New Antibodies for Up to $8 Billion
01/10	Sanofi, Regeneron Expand Immunology Partnership in $1 Billion Deal
01/10	Sanofi zahlt für neue Antikörper bis zu acht Milliarden Dollar an Regeneron
01/10	Regeneron Pharmaceuticals, Inc. And Sanofi Expand Global Alliance With Multiple Next-Generation, Long-Acting Immunology Antibodies
01/10	Sanofi : accordo da 1 mld $ con Regeneron per sviluppo nuovi anticorpi
01/10	Sanofi und Regeneron erweitern Allianz in Milliardendeal
01/10	Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion
01/10	Sanofi, Regeneron Expand Immunology Partnership in Up to $8 Billion Deal
01/10	Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies
01/10	Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies
01/10	Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial
01/10	Regeneron drug halves muscle loss in combination with Novo's semaglutide in trial
30/09	Major drugmakers turn to China for licensing deals
29/09	Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says
29/09	Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026